Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
about
Recent advances in primary Sjogren's syndromeRituximab Effectiveness and Safety for Treating Primary Sjögren's Syndrome (pSS): Systematic Review and Meta-AnalysisIs salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic reviewMultiple Roles for B-Lymphocytes in Sjogren's SyndromeReviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatmentTreatment of primary Sjögren syndrome.High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data from the TEARS Randomized Trial.Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.Pediatric Sjogren syndrome with distal renal tubular acidosis and autoimmune hypothyroidism: an uncommon association.Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.Rituximab in primary Sjögren's syndrome: a ten-year journey.Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureImmunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies.Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndromeLung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.Classification criteria and treatment modalities in primary Sjögren's syndrome.Fatigue in psoriasis: a phenomenon to be explored.Efficacy and safety of rituximab in rheumatic diseases.Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.Renal involvement in primary Sjögren's syndrome.Recommendations for the treatment of Sjögren's syndrome.The continuing evolution of targeted therapy for inflammatory skin disease.Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Safety of treatments for primary Sjögren's syndrome.Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.Present and future of biologic drugs in primary Sjögren's syndrome.New Treatment Guidelines for Sjögren's Disease.Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease.Sjögren Syndrome and Other Causes of Sicca in Older Adults.Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
P2860
Q26747049-F0CC3723-308C-4A47-9388-F808E1237531Q26753072-3B02EBF1-C40F-4F93-BDA9-E14DD33DB6D0Q26775918-C8C870FF-3211-490D-93A8-1B9BD18DB4B9Q28068695-7AC73B0D-6FBE-4F18-85E3-E56F5128A91AQ30234992-14091C6E-EE1F-4AF4-AE3A-6D1B5F9C6225Q30249011-E8053655-75F6-40C0-B1D0-E1C8D6CD1E13Q30372606-811944C9-5E6B-41D0-BABA-906F9801E2A5Q30948155-FFE3DBEC-BE03-4CBC-89BF-225ECF71970BQ33622265-172E15B1-B6B9-481C-8B29-54AE93D9886AQ33907242-300A960E-FBDB-465B-BDA4-5A595F6EA121Q34432465-8123A473-DE43-4386-AFE5-5BE3D21DE717Q35196207-263613D5-29F7-4D56-8984-D23D9E1FA13DQ35774612-C0147FB3-B700-45C9-9CEB-4694946DA231Q36070691-A454EB0F-D2A2-4106-9946-A2F94386C224Q36219673-74A2A6E9-D32C-4B29-8B0B-8E97E455426CQ36481706-7804C0BC-D2E8-4C23-9E7F-372E27FB3787Q36484460-B59348FC-0855-4D81-A7BC-068C69433816Q36903959-A2F28689-A941-431B-B90D-497ABB7F06A8Q37690737-DB365551-5A86-447E-9E5C-601270A3A425Q38197287-6DACF7B6-6BF5-4478-8B3D-32C2F472409FQ38306698-15A37AAD-9C1B-41AD-9656-58EC6322890CQ38353577-38A431B9-AC7E-4CE5-870C-86AEC5CA3623Q38401667-F4BF6FBC-517B-416C-BB60-049CF5D7144DQ38526786-533CF9DE-97D9-420D-A6B9-6F9AFD3656F9Q38584878-696D5EC7-1A89-4E1E-99DA-94C8D65B2539Q38596134-7A5E083C-DEE4-448D-B9ED-1C6817FD3183Q38645543-F3195566-EC77-43BC-8244-B04590D0F702Q38676903-487D7477-F854-4751-A413-3D0140F67FF0Q38711144-8EDE5FE3-A5C7-4386-88D3-28AA03FB0591Q38795404-0C6BE51C-283E-4FFE-9A2B-3BA55F9C96ABQ38822415-4CA74A10-0BA1-426B-8F6F-EF6826C532E7Q38840388-6FF21435-BAB8-4E7B-9925-C0B929E39B03Q38889818-C80686DB-B80D-4835-8D76-FC12F38F7A55Q38906337-0C26574B-0818-4577-9FFD-78974D197A8EQ38988830-D0B8E271-90B9-4E96-812E-8304AAFDB8B0Q39019614-EACCDAFF-9729-4080-BF1A-8FC091E75ADBQ39081726-B4028A4C-0EBE-42D1-A8E3-CDB969425303Q40067064-4642CEA7-F1C3-403D-8D11-E8E755F450B0Q40117123-D1E01C32-A9CF-4D1C-936A-47F8B70E7867Q40383414-CA3957B7-463F-4EC5-9B58-3A7A4828A179
P2860
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@en
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@nl
type
label
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@en
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@nl
prefLabel
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@en
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@nl
P2093
P50
P356
P1476
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
@en
P2093
Aleth Perdriger
Charles Zarnitsky
Emmanuel Nowak
Gilles Hayem
Jacques Morel
Jacques-Eric Gottenberg
Jean Jacques Dubost
Jean Sibilia
Laurent Chiche
Pierre Yves Hatron
P304
P356
10.7326/M13-1085
P407
P50
P577
2014-02-01T00:00:00Z